X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

KNTE

Closed

Kinnate Biopharma inc

2.65
-0.01 (-0.38%)
Last Update: 03 Apr 2024 23:00:00
Yesterday: 2.66
Day's Range: 2.65 - 2.65
Send
When Written:
 
6.11
Kinnate Biopharma Inc is a clinical-stage biopharmaceutical company that is focused on developing precision medicines for patients with genomically defined cancers. The company's approach is to use its proprietary platform to identify and develop therapies that target specific genetic mutations that drive cancer growth. Kinnate's lead product candidate is KIN-2787, a potent and selective inhibitor of FGFR2 and other FGFR family members, which is being developed for the treatment of solid tumors. The company was founded in 2018 and is headquartered in San Diego, California. Kinnate Biopharma Inc is a publicly traded company listed on the NASDAQ under the ticker symbol "KNTE".

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X